Company news
Cambridge Cognition Holdings Plc (LSE:COG) news
Every Cambridge Cognition Holdings Plc press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
TR-1: Notification of Major Holdings
July 15, 2026
Result of GM, TVR & Director/PDMR Dealing
July 10, 2026
Result of Retail Offer
June 30, 2026
Retail Offer
June 24, 2026
Proposed Equity Fundraising and Retail Offer
June 23, 2026
COG to present at Mello 2026
June 1, 2026
Launch of brain health study with Oura
May 28, 2026
Posting of Annual Report & Notice of AGM
April 24, 2026
Results for the year ended 31 December 2025
April 13, 2026
Notice of Results
April 7, 2026
Block Listing Return
April 1, 2026
Monument Therapeutics MT1988 First Patient Dosed
March 11, 2026
Cambridge Cognition Partners With Ivory to Scale Early Cognitive Screening With CANTAB Pathway™ in India
February 17, 2026
Commercialisation Agreement
February 16, 2026
Change of Joint Broker
February 9, 2026
Trading Update
January 19, 2026
Change of Auditor
November 5, 2025
Exercise of Options and Total Voting Rights
September 29, 2025
Holding(s) in Company
September 26, 2025
Investor Presentation via Investor Meet Company
September 1, 2025
£1.12m Placing & Subscription, TVR & PDMR Dealings
August 28, 2025
Monument Therapeutics Partnership with FNIH
August 19, 2025
Launch of Speaker Identification Solution
August 12, 2025
Trading update for period ended 30 June 2025
July 31, 2025
Result of AGM
June 27, 2025
Monument Therapeutics Success in Phase I Results
June 24, 2025
Notice of AGM
June 4, 2025
Preliminary Unaudited Results
May 1, 2025
Notice of Results and Investor Presentation
April 24, 2025
Contract Win
April 10, 2025
CANTAB® used for major global brain health study
March 6, 2025
Cambridge Cognition submits FDA Letter of Intent
February 18, 2025
Board Appointment
February 7, 2025
Launch of in-house rater training service
January 21, 2025
Expanded partnership with Actinogen
January 16, 2025
CANTAB® success in Bristol Myers Squib research
January 8, 2025
Director/PDMR Share Purchases
December 27, 2024
Monument Therapeutics secures £1m investment
November 6, 2024
New data demonstrates effectiveness of AQUA
October 31, 2024
Directorate Change
October 18, 2024
Directorate change
September 12, 2024
Interim Results
August 22, 2024
Issue of Equity and Total Voting Rights
July 26, 2024
Trading Update & Board Change
July 23, 2024
Cambridge Cognition secures Innovate UK grant
July 11, 2024
Grant of Options
July 1, 2024
Result of AGM & Change of Name of NOMAD & Broker
June 28, 2024
Results of GM, Open Offer, TVR and PDMR Dealing
June 17, 2024
Circular Publication and Notice of General Meeting
May 31, 2024
Result of Placing and Subscription
May 30, 2024